SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-025279
Filing Date
2019-12-04
Accepted
2019-12-04 09:26:22
Documents
7
Period of Report
2019-12-04

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT OF FOREIGN ISSUER f6k120319_therapixbio.htm 6-K 16896
2 OPINION OF HORN & CO. LAW OFFICES. f6k120319ex5-1_therapix.htm EX-5.1 12322
3 FORM OF SECURITIES PURCHASE AGREEMENT BETWEEN THE COMPANY AND THE PURCHASERS IN f6k120319ex10-1_therapix.htm EX-10.1 176707
4 PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON DECEMBER 4, 2019, TITLED "T f6k120319ex99-1_therapix.htm EX-99.1 8188
5 GRAPHIC ex99-1_001.jpg GRAPHIC 29043
6 GRAPHIC image_001.jpg GRAPHIC 5909
7 GRAPHIC image_002.jpg GRAPHIC 11861
  Complete submission text file 0001213900-19-025279.txt   280070
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 191267483
SIC: 2834 Pharmaceutical Preparations